ArticleCureus2023

Real-World Use of Albutrepenonacog Alfa, A Recombinant Coagulation Factor IX Albumin Fusion Protein, for Personalized Prophylaxis in Japanese Individuals With Hemophilia B: A Case Series.

Azusa Nagao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.